The Platform Group in the news
Operating platform solutions in multiple industries
Tamtam found 16 recent articles about The Platform Group.
- The Platform Group verhandelt Übernahme im Pharma-Plattformbereich und prüft Aufstockung der Anleihe
The Platform Group AG is negotiating to acquire three pharmaceutical platform companies to significantly boost revenue and is considering increasing its corporate bond to finance the deal.
- The Platform Group AG: HV stimmt Formwechsel in SE & Co. KGaA zu
The Platform Group AG approved a legal form change with 99% shareholder support, reported record financials, and plans significant expansion across industries.
- Original-Research: The Platform Group AG (von First Berlin Equity Research Gm... - boerse.de
The Platform Group AG raised its 2026 revenue and profit forecasts following three pharma acquisitions, increasing its price target to EUR20 with a Buy rating.
- Original-Research: The Platform Group AG (von First Berlin Equity Research GmbH): Buy - boerse.de
The Platform Group AG raised its 2026 revenue forecast following three pharma acquisitions and increased its price target to €20 with a Buy rating.
- The Platform Group: 2026 Prognose 1 Mrd. Umsatz, 80 Mio. EBITDA
The Platform Group AG raised its 2026 revenue forecast to EUR 1 billion, driven by organic growth and acquisitions in pharma and optics sectors.
- Original-Research: The Platform Group AG (von NuWays AG): BUY
The Platform Group AG raised its FY'26 targets and target price after acquiring stakes in pharma companies to strengthen its B2B pharmacy platform and expanding into profitable optics and hearing markets.
- The Platform Group Boosts 2026 Forecast to €1B Sales with Pharma Acquisitions
The Platform Group AG raised its 2026 sales and EBITDA forecasts due to acquisitions in pharma and optics sectors, planning further deals by 2025.
- Correction of a release from 02/10/2025, 10:25 CET/CEST - The Platform Group AG raises its forecast for 2026 to EUR 1 billion in sales and EUR 70-80 million in EBITDA - three acquisitions in the pharmaceutical sector and expansion in the Optics & Hearing
The Platform Group AG updated its 2026 forecast with higher sales and EBITDA, highlighted acquisitions in pharmaceuticals, and corrected shareholding details.
- The Platform Group AG (TPG) korrigiert und konkretisiert Corporate News
The Platform Group AG raised its 2026 revenue and EBITDA forecasts due to acquisitions and organic growth, correcting a prior forecast error.
- Correction of a release from 02/10/2025, 10:25 CET/CEST - The Platform Group AG raises its forecast for 2026 to EUR 1 billion in sales and EUR 70–80 million in EBITDA – three acquisitions in the pharmaceutical sector and expansion in the Optics & Hearing
The Platform Group AG raised its 2026 sales and EBITDA forecast due to organic growth and multiple acquisitions in pharmaceuticals and optics & hearing sectors.
- Korrektur der Veröffentlichung vom 02.10.2025, 10:25 Uhr CET/CEST - The Platform Group AG hebt Prognose für 2026 auf EUR 1 Mrd. Umsatz und EUR 70–80 Mio. EBITDA an – drei Akquisitionen im Pharmabereich sowie Erweiterung im Segment Optics & H
The Platform Group AG raised its 2026 revenue and EBITDA forecasts due to organic growth and multiple acquisitions in pharma and optics sectors.
- The Platform Group Targets EUR 1 Billion in Revenue for 2026, Completes Three Acquisitions in the Pharmaceutical Sector
The Platform Group AG plans EUR 1 billion revenue by 2026 after acquiring three pharmaceutical companies and expanding its service goods segment.
- The Platform Group AG hebt Prognose für 2026 auf EUR 1 Mrd. Umsatz und EUR 70–80 Mio. EBITDA an – drei Akquisitionen im Pharmabereich sowie Erweiterung im Segment Optics & Hearing
The Platform Group AG raised its 2026 revenue and EBITDA forecasts due to three pharmaceutical acquisitions and expansion in optics and hearing segments.
- The Platform Group Eyes EUR 1B Revenue with Pharma Acquisitions
The Platform Group AG plans to reach EUR 1 billion revenue by 2026 through pharma acquisitions and segment expansion.
- The Platform Group AG hebt Prognose für 2026
The Platform Group AG raised its 2026 revenue and EBITDA forecasts following three pharmaceutical sector acquisitions and expansion in optics and hearing segments.
- The Platform Group AG: Exklusive Strategie-Session – Jetzt Anmelden!
The Platform Group AG announced a strategy session covering business updates and future outlook, with a recent stock price decline.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like The Platform Group?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies